<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0005048'>Thrombosis</z:mp> and <z:mp ids='MP_0001845'>inflammation</z:mp> are hallmarks of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> still unamenable to therapeutic interventions </plain></SENT>
<SENT sid="1" pm="."><plain>High-molecular-weight kininogen (KNG) is a central constituent of the contact-kinin system which represents an interface between thrombotic and inflammatory circuits and is critically involved in <z:hpo ids='HP_0001297'>stroke</z:hpo> development </plain></SENT>
<SENT sid="2" pm="."><plain>Kng(-/-) mice are protected from <z:mp ids='MP_0005048'>thrombosis</z:mp> after artificial vessel wall injury and lack the proinflammatory mediator bradykinin </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the consequences of KNG deficiency in models of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Kng(-/-) mice of either sex subjected to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> developed dramatically smaller <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> and less severe neurologic deficits without an increase in <z:mpath ids='MPATH_124'>infarct</z:mpath>-associated <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>This protective effect was preserved at later stages of infarction as well as in elderly mice </plain></SENT>
<SENT sid="6" pm="."><plain>Targeting KNG reduced <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in ischemic vessels and improved cerebral blood flow, and reconstitution of KNG-deficient mice with human KNG or bradykinin restored clot deposition and <z:mpath ids='MPATH_124'>infarct</z:mpath> susceptibility </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, mice deficient in KNG showed less severe blood-brain barrier damage and <z:hpo ids='HP_0000969'>edema</z:hpo> formation, and the local <z:mp ids='MP_0001845'>inflammatory response</z:mp> was reduced compared with controls </plain></SENT>
<SENT sid="8" pm="."><plain>Because KNG appears to be instrumental in pathologic <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and <z:mp ids='MP_0001845'>inflammation</z:mp> but dispensable for hemostasis, KNG inhibition may offer a selective and safe strategy for combating <z:hpo ids='HP_0001297'>stroke</z:hpo> and other <z:hpo ids='HP_0001907'>thromboembolic diseases</z:hpo> </plain></SENT>
</text></document>